Trovagene Teams with Brazilian Partner on HPV Test Evaluation | GenomeWeb

NEW YORK (GenomeWeb News) – Trovagene today said that it will collaborate with the PIO XII Foundation in Brazil to evaluate the performance of the firm's urine-based molecular assay for HPV types associated with cervical lesions.

The goal of the study is to determine if the test could potentially replace Pap smears as a primary screening tool for cervical cancer risk within Brazil's healthcare system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.